Application 021351

Type
NDA
Sponsor
ALLERGAN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
002OXYTROLOXYBUTYNINFILM, EXTENDED RELEASE;TRANSDERMAL3.9MG/24HRYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0023-6153OXYTROLOxybutyninAllergan, Inc.NDACurrent
0023-6153OXYTROLOxybutyninAllergan, Inc.NDACurrent
0023-6153OXYTROLOxybutyninAllergan, Inc.NDACurrent
52544-920OXYTROLOxybutyninActavis Pharma, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
78601SUPPL 2024-09-06
78578SUPPL 2024-05-30
50221SUPPL2017-10-30
50220SUPPL2017-10-30
50172SUPPL2017-10-25
50171SUPPL2017-10-25
15259SUPPL2015-07-13
5132SUPPL2015-07-13
36733SUPPL2012-10-12
27565SUPPL2012-10-12
15258SUPPL2012-10-12
5131SUPPL2012-10-12
5130SUPPL2011-02-03
36732SUPPL2011-01-31
5129SUPPL2006-07-13
36731SUPPL2006-07-07
42116ORIG2005-04-08
27564ORIG2003-03-10
15257ORIG2003-02-26